Anxiety: The Evidence-Based Supplement Protocol

← Back to articles

For diagnosed generalized anxiety disorder, SSRIs and cognitive behavioral therapy remain first-line and most effective. But several supplements have credible RCT evidence for subclinical and mild-to-moderate anxiety symptoms, with substantially better tolerability than benzodiazepines and no dependence liability. The five with the strongest data are magnesium, ashwagandha, L-theanine, oral lavender oil (Silexan), and saffron.

Magnesium Glycinate, 200–300 mg Elemental Nightly

A 2017 systematic review of 18 trials concluded that magnesium produced modest reductions in subjective anxiety in mildly anxious adults. Effect is largest in those with low dietary intake. Take with the evening meal; glycinate or threonate form preferred for tolerability. See our magnesium for anxiety piece.

Ashwagandha (KSM-66 or Shoden), 300–600 mg Daily

Multiple RCTs at 300–600 mg daily of standardized extract for 8 weeks have shown significant reductions in Perceived Stress Scale and serum cortisol versus placebo. A 2021 meta-analysis of 12 RCTs confirmed the anxiety reduction. Cycle 8 weeks on / 2 weeks off; avoid in hyperthyroidism. See our ashwagandha overview and the anti-anxiety stack.

L-Theanine, 200 mg as Needed

L-theanine produces alpha-wave EEG activity within 30–40 minutes and acute reductions in subjective stress in multiple RCTs. Useful before stressful events. Does not cause sedation or tolerance. See L-theanine dossier.

Oral Lavender Oil (Silexan), 80 mg Daily

Silexan is a standardized oral lavender oil with a European pharmaceutical license for anxiety. Multiple RCTs versus placebo and an active comparison trial against paroxetine 20 mg have shown comparable anxiolytic effects in generalized anxiety disorder, with substantially better tolerability than benzodiazepines. See our Silexan piece.

Saffron, 30 mg Daily

Saffron at 30 mg daily has shown anxiolytic effects in multiple Iranian RCTs versus placebo and in head-to-head trials against fluoxetine 20 mg in adults with mild-to-moderate anxiety-depressive mixed presentations. Effect size modest. See our saffron review.

What NOT to Take

Kava has real anxiolysis but a documented hepatotoxicity signal that led to European bans — see our kava CDC piece. Valerian's anxiolytic evidence in adults is weak and inconsistent. CBD has emerging social-anxiety data but supply quality is poor — see our CBD review. Avoid stacking ashwagandha or Silexan with benzodiazepines, SSRIs, or thyroid replacement without prescriber sign-off.

How to Run the Protocol

For mild anxiety, start magnesium 200 mg + L-theanine 200 mg as-needed for 4 weeks. Add ashwagandha 300 mg daily at week 4 if chronic-load anxiety persists. For moderate anxiety, Silexan 80 mg daily is the strongest single-agent option. None of these replace cognitive behavioral therapy or SSRI/SNRI in diagnosed GAD. Track a 0–10 daily anxiety score; a sustained 2-point drop is the response benchmark.